Back to Results
First PageMeta Content
Pharmacology / Pharmaceuticals policy / Federal assistance in the United States / Healthcare reform in the United States / Presidency of Lyndon B. Johnson / Medicaid / Patient Protection and Affordable Care Act / Pharmacy benefit management / Medicare / Health / Pharmaceutical sciences / Medicine


GAO-14-68, Medicaid Prescription Drugs: CMS Should Implement Revised Federal Upper Limits and Monitor Their Relationship to Retail Pharmacy Acquisition Costs [Reissued on February 6, 2014]
Add to Reading List

Document Date: 2014-02-06 15:10:22

Open Document

File Size: 1,18 MB

Share Result on Facebook

City

Washington / DC / Washington / D.C. / Washington D.C. / /

Company

Myers and Stauffer LC / Medicare & Medicaid Services / DataBank / /

Country

United States / /

Currency

USD / /

/

Event

Company Expansion / /

IndustryTerm

retail pharmacies / retail community pharmacy / average retail pharmacy / retail pharmacy / retail pharmacy acquisition costs / selected retail community pharmacies / retail community pharmacies / public accounting / pharmaceutical manufacturers / retail prices / /

Organization

United States Senate / Congress / office of Inspector General / Honorable Max Baucus Chairman Committee / federal government / GAO / U.S. government / HHS office of Inspector General / National Association of State Medicaid Directors / Department of Health and Human Services National Average Drug Acquisition Cost / Honorable Charles E. Grassley Ranking Member Committee on the Judiciary United States Senate Medicaid / Department of Health and Human Services / HHS OIG / Medicare / /

Person

John E. Dicken / /

/

Position

Governor / Executive / Administrator / /

Product

Medicaid / NADACs / PPACAbased FULs / Medicaid prescriptions / /

ProgrammingLanguage

DC / /

URL

http /

SocialTag